Sunday, May 21, 2023

 

FTC Deepens Inquiry into Prescription Drug Middlemen

3 days ago — They influence which drugs are prescribed to patients, which pharmacies patients can use, and how much patients ultimately pay at the pharmacy counter. PBMs ...

FTC expands probe into pharmacy benefit managers to GPOs By Paige MinemyerMay 17, 2023 04:50pm

https://www.fiercehealthcare.com/regulatory/ftc-expands-probe-pharmacy-benefit-managers-gpos 

 

Report-of-the-Committee-on-Law-Enforcement-Legislation- ...

4 days ago — USP <825> clarifies that nuclear pharmacies primarily dispense rather than compound drug products. The definitions for Compounding, Preparation with Minor 

 

Makena End of Coverage and Removal from ...

6 days ago — FDA approvals of these drugs were withdrawn. ... Makena and its generics, as well as Compounded 17P, are no longer covered at point-of-sale effective April ...

 

Compounding pharmacies can help address drug shortages

6 days ago — State-licensed compounding pharmacies should be able to provide urgent-use medications within tight regulatory guardrails.

 

Some Pharmacies Are Offering Unauthorized Ozempic ...

5 days ago — The F.D.A. does not vet compounded medications, and has not reviewed, approved or tested — for safety or effectiveness — the semaglutide drugs compounding ...

 

 

Friday, May 12, 2023

 FDA is notifying consumers of certain products promoted for sexual enhancement that have been found to contain hidden ingredients and might pose a significant health risk: 

Immediate public notifications are issued when FDA testing finds that a product contains active drug ingredients not listed on the product labels, possibly including ingredients found in prescription drugs. These products might cause potentially serious side effects and might interact with medications or dietary supplements a consumer is taking. Consumers should use caution when considering purchasing these types of products. 

Learn More